ALTAVANT SCIENCES HOLDINGS LIMITED - LONDON
Company Profile | Company Filings |
Overview
ALTAVANT SCIENCES HOLDINGS LIMITED is a Private Limited Company from LONDON UNITED KINGDOM and has the status: Active.
ALTAVANT SCIENCES HOLDINGS LIMITED was incorporated 6 years ago on 11/10/2017 and has the registered number: 11007316. The accounts status is FULL and accounts are next due on 31/12/2024.
ALTAVANT SCIENCES HOLDINGS LIMITED was incorporated 6 years ago on 11/10/2017 and has the registered number: 11007316. The accounts status is FULL and accounts are next due on 31/12/2024.
ALTAVANT SCIENCES HOLDINGS LIMITED - LONDON
This company is listed in the following categories:
64209 - Activities of other holding companies n.e.c.
64209 - Activities of other holding companies n.e.c.
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
31 / 3 | 31/03/2023 | 31/12/2024 |
Registered Office
7TH FLOOR
LONDON
SW1H 0DB
UNITED KINGDOM
This Company Originates in : United Kingdom
Previous trading names include:
PULMOVANT HOLDINGS LIMITED (until 29/06/2018)
PULMOVANT HOLDINGS LIMITED (until 29/06/2018)
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
10/10/2023 | 24/10/2024 |
Map
UNITED KINGDOM
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
VISTRA COSEC LIMITED | Corporate Secretary | 2017-10-11 | CURRENT | ||
MR JASON ANTONY READER | Aug 1972 | British | Director | 2017-10-11 | CURRENT |
EMMA CARYS PRICE | Aug 1993 | British | Director | 2023-10-06 | CURRENT |
MR SUNIL MASSON | Nov 1971 | British | Director | 2019-08-16 UNTIL 2022-08-05 | RESIGNED |
MR MARK CRAIG | May 1974 | British | Director | 2022-08-05 UNTIL 2023-10-06 | RESIGNED |
REUBEN JAMES ANSTOCK | Nov 1981 | British | Director | 2018-01-30 UNTIL 2019-08-16 | RESIGNED |
VANT DIRECTOR SERVICES LIMITED | Corporate Director | 2017-10-11 UNTIL 2018-01-30 | RESIGNED |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Sumitomo Pharma Co., Ltd. | 2019-12-27 | Osaka,541-0045 Osaka |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
Altavant Sciences Holdings Limited - Limited company accounts 20.1 | 2021-12-23 | 31-03-2021 | $207,265 equity |